What is CONMED's R&D?

CONMED (CNMD) reported R&D of $16.33M in Q1 2026.

How has CONMED's R&D changed year-over-year?

CONMED's R&D increased by 26.2% year-over-year, from $12.95M to $16.33M.

What is the long-term trend for CONMED's R&D?

Over 4 years (2021 to 2025), CONMED's R&D has grown at a 6.4% compound annual growth rate (CAGR), from $43.57M to $55.89M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

CONMED CNMD R&D

R&D at other companies

StrykerSYK

$413M+2.0%

VericelVCEL

$8.1M+11.6%

OSI SystemsOSIS

$19.46M+4.8%

Zimmer Biomet HoldingsZBH

$103.4M-6.5%

MedtronicMDT

$671M-1.9%

IAR

Integra LifeSciencesIART

$23.5M-5.0%

Other financials

Income statement

See full

Revenue$317.0M-1.3%

Gross profit$183.4M+3.2%

Operating income$25.4M+59.3%

Net income$13.8M+129%

EPS (diluted)$0.45+137%

Balance sheet

See full

Cash & equivalents$35.0M-1.3%

Total debt$862.6M-3.6%

Total equity$1.0B+4.1%

Total assets$2.3B+0.8%

Cash flow

See full

Operating cash flow$13.5M-67.6%

CapEx$2.9M-23.5%

Free cash flow$10.6M-72.0%

Valuation

See full

Market cap$1.07B-35.6%

Enterprise value$1.89B-24.5%

P/E19.4×+5.5×

P/S0.8×-0.5×

Profitability

See full

Gross margin55.2%-1.0pp

Operating margin8.2%-5.6pp

Net margin4%-5.0pp

FCF margin9%-3.5pp

Returns & leverage

See full

Return on equity5.5%-7.5pp

Debt / equity0.8×-0.1×

Current ratio2.3×0.0×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CONMED's R&D?: CONMED (CNMD) reported R&D of $16.33M in Q1 2026.
How has CONMED's R&D changed year-over-year?: CONMED's R&D increased by 26.2% year-over-year, from $12.95M to $16.33M.
What is the long-term trend for CONMED's R&D?: Over 4 years (2021 to 2025), CONMED's R&D has grown at a 6.4% compound annual growth rate (CAGR), from $43.57M to $55.89M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.